NEXGEL, Inc. (NASDAQ:NXGLW) Sees Large Decline in Short Interest

NEXGEL, Inc. (NASDAQ:NXGLW) was the recipient of a significant decline in short interest during the month of June. As of June 15th, there was short interest totaling 125 shares, a decline of 91.9% from the May 31st total of 1,534 shares. Based on an average trading volume of 5,691 shares, the days-to-cover ratio is currently 0.0 days.

NEXGEL Stock Down 10.4%

Shares of NASDAQ NXGLW opened at $0.02 on Friday. NEXGEL has a 12-month low of $0.02 and a 12-month high of $0.36. The company has a 50-day moving average of $0.05 and a 200 day moving average of $0.11.

NEXGEL Company Profile

NEXGEL, Inc manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name.